Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a narrative review synthesizing mechanistic evidence from disparate studies without presenting primary empirical data, clinical outcomes, or a systematic synthesis; it raises questions about tannic acid's potential rather than answering them with controlled evidence.
A mechanistic study in cell and transgenic mouse models showing FGF17 delivery reduces Aβ deposition and apoptosis with pathway confirmation, but lacking human efficacy data and powered clinical outcomes.